These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15282070)

  • 1. [Severe thrombocytopenia refractory to platelet transfusions, secondary to abciximab readministration, in a patient previously diagnosed with idiopathic thrombocytopenic purpura. A possible etiopathogenic link].
    Méndez TC; Díaz O; Enríquez L; Baz JA; Fernández F; Goicolea J
    Rev Esp Cardiol; 2004 Aug; 57(8):789-91. PubMed ID: 15282070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound delayed thrombocytopenia presenting 16 days after Abciximab (Reopro®) administration.
    Webb GJ; Swinburn JM; Grech H
    Platelets; 2011; 22(4):302-4. PubMed ID: 21526887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.
    Berkowitz SD; Harrington RA; Rund MM; Tcheng JE
    Circulation; 1997 Feb; 95(4):809-13. PubMed ID: 9054735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy.
    Jubelirer SJ; Koenig BA; Bates MC
    Am J Hematol; 1999 Jul; 61(3):205-8. PubMed ID: 10398314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
    Nguyen N; Salib H; Mascarenhas DA
    J Invasive Cardiol; 2001 Jan; 13(1):56-8. PubMed ID: 11146690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion.
    Kereiakes DJ; Essell JH; Abbottsmith CW; Broderick TM; Runyon JP
    Am J Cardiol; 1996 Nov; 78(10):1161-3. PubMed ID: 8914883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute profound thrombocytopenia following abciximab therapy.
    Bishara AI; Hagmeyer KO
    Ann Pharmacother; 2000; 34(7-8):924-30. PubMed ID: 10928405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute severe thrombocytopenia after treatment with ReoPro (abciximab).
    Butler R; Hubner PJ
    Heart; 2000 Apr; 83(4):E5. PubMed ID: 10722557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute profound thrombocytopenia without bleeding complications after abciximab administration.
    Elmi F; Oza R; Mascarenhas DA
    J Invasive Cardiol; 1999 May; 11(5):313-5. PubMed ID: 10745539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
    Kereiakes DJ; Berkowitz SD; Lincoff AM; Tcheng JE; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf RM; Topol EJ
    Am Heart J; 2000 Jul; 140(1):74-80. PubMed ID: 10874266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia associated with c7E3 Fab (abciximab).
    Schell DA; Ganti AK; Levitt R; Potti A
    Ann Hematol; 2002 Feb; 81(2):76-9. PubMed ID: 11907786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute profound thrombocytopenia associated with the use of abciximab: case report].
    Álvarez-Camarena B; Frutos-Rangel E; Rico-Curiel E; García-y Otero JM; Frutos-Rodríguez E
    Arch Cardiol Mex; 2011; 81(4):317-21. PubMed ID: 22188887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of pseudothrombocytopenia after infusion of abciximab in vivo and anticoagulant-independent platelet clumping after rechallenge with abciximab in vitro.
    Kozak M; Dovc T; Rozman P; Blinc A
    Wien Klin Wochenschr; 2000 Feb; 112(3):138-41. PubMed ID: 10729966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abciximab readministration.
    Orford JL; Holmes DR
    Rev Cardiovasc Med; 2002; 3(2):67-70. PubMed ID: 12447149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent thrombosis following thrombocytopenia remission--a case report].
    Elikowski W; Rzeźniczak J; Słomczyński M; Psuja P
    Kardiol Pol; 2005 Jan; 62(1):44-7; discussion 48. PubMed ID: 15815778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute profound thrombocytopenia after abciximab therapy during coronary angioplasty.
    Joseph T; Marco J; Gregorini L
    Clin Cardiol; 1998 Nov; 21(11):851-2. PubMed ID: 9825202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.
    Davidson SJ; Turner N; Clague JR; Oldershaw PJ; Burman JF
    Thromb Haemost; 1999 Nov; 82(5):1560-1. PubMed ID: 10595660
    [No Abstract]   [Full Text] [Related]  

  • 18. Abciximab-induced thrombocytopenia.
    Griffiths C; Fisher M
    QJM; 2002 Sep; 95(9):635-6. PubMed ID: 12205341
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention.
    Fahdi IE; Saucedo JF; Hennebry T; Ghani M; Sadanandan S; Garza-Arreola L
    Am J Cardiol; 2004 Feb; 93(4):453-5. PubMed ID: 14969621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy.
    Reddy MS; Carmody TJ; Kereiakes DJ
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):486-8. PubMed ID: 11285605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.